Tag: Blepharitis

Dupilumab-associated ocular adverse event in patients with atopic dermatitis

Authors: Chen Wei,  Ma Li,  Waichlam Lam DOI: 10.3760/cma.j.cn115989-20200126-00041 Published 2022-03-10 Cite asChin J Exp Ophthalmol, 2022, 40(3): 276-279. Abstract Atopic dermatitis (AD) is a chronic, relapsing, pruritic inflammatory skin disease.Dupilumab is a monoclonal antibody that inhibits interleukin (IL)-4 and IL-13 signaling pathways through its binding to IL-4α receptor, which has been demonstrated effective in […]